NCT04837248

Brief Summary

Breast cancer surgery usually results in reduced range of motion of the shoulder joint, weakness of the musculature and altered scapular kinematics during movement. These factors limit activities of daily living, so rehabilitation exercises help to restore function after shoulder surgery. Women with breast cancer often have a life conditioned by the sequelae or morbidity secondary to the treatment of the disease and, despite the high cure rate, many patients are unable to regain their initial quality of life. Cancer therapies can leave physical, psychological and psychosocial sequelae, which may manifest themselves or persist even years after the end of treatment. For all these reasons, patients who have undergone cancer treatment need physical rehabilitation as well as psychological and social care to support them in their new stage of life, and to optimise the rehabilitation programme, it is necessary to identify each patient's individual needs, The digital support proposed in this study enables the development of a physiotherapy programme for patients with breast cancer in a situation of health crisis, which includes providing assistance, information, accompaniment, help and treatment to these patients in a comprehensive way, based on the biopsychosocial model.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable breast-cancer

Timeline
Completed

Started Aug 2021

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 6, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 8, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

August 2, 2021

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

February 26, 2025

Status Verified

February 1, 2025

Enrollment Period

3.2 years

First QC Date

April 6, 2021

Last Update Submit

February 24, 2025

Conditions

Keywords

ExerciseMuscle WeaknessLymphedemaFatigueDepression

Outcome Measures

Primary Outcomes (2)

  • Disabilities of the Arm, Shoulder and Hand Score (DASH)

    Global assessment of the functionality of the upper limb,

    12 weeks

  • Disabilities of the Arm, Shoulder and Hand Score (DASH)

    Global assessment of the functionality of the upper limb,

    3 months

Secondary Outcomes (5)

  • European organization for research and treatment of cancer quality life questionnaire core 30. (QLQ-C30-B23)

    12 weeks

  • Range Of Motion (ROM)

    12 weeks

  • Tampa Scale for Kinesiophobia (TSK-11SV)

    12 weeks

  • Brief Pain Inventory (BPI)

    12 weeks

  • Hospital Anxiety and Depression Scale (HADS)

    12 weeks

Study Arms (2)

Group 1. Conventional treatment

ACTIVE COMPARATOR

Patients will be treated with a physiotherapy programme without digital support.

Other: Active Comparator: Group 1. Conventional treatment

Group 2. Experimental treatment.

EXPERIMENTAL

Patients will be treated using a digitally supported physiotherapy programme.

Other: Experimental: Group 2. Experimental treatment.

Interventions

Patients will be treated using a physiotherapy programme without digital support. A written document with exercises and recommendations will be given to them on the first day. This booklet will detail the exercises they can do depending on their surgery and the weeks elapsed, as well as the recommendations adapted according to the needs identified in the motivational interview (MI). This is the treatment that is currently being applied in the hospital. The patient will carry out the treatment at home and will come back after 20 sessions for the corresponding assessment.

Group 1. Conventional treatment

A digitally supported physiotherapy programme including: * Group session: expectations, interests, experiences with regard to their health problem and the consequences on their life, joint exercise and discussion with subsequent debate will be held. * Exercise session: each week, patients will find different exercise videos on the platform according to the phase of recovery in which each one of them is, having been previously evaluated in the group session. * Relaxation session: this will be carried out by means of audio that will be posted on the platform and that the patient will be able to perform simultaneously. * Empowerment session: audio sessions that will deal with those needs that frequently arise after breast surgery in their daily lives, focusing on limiting beliefs (e.g. fear of moving), positive thoughts and information extracted from the motivational interview that should be developed.

Group 2. Experimental treatment.

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of stage I, II or III of Breast cancer treated by surgery.
  • Medical authorisation for participation.
  • Internet access.
  • Basic computer skills.
  • Signed informed consent.
  • No bilateral mastectomy.
  • No metastases.
  • Post-intervention period of 10 days to 3 months.
  • Age 18-85 years.
  • No previous shoulder pathologies.
  • No pathology that prevents exercise.
  • Understanding of the Spanish language.

You may not qualify if:

  • Breast cancer treated without surgery.
  • Patient in severe psychiatric treatment who may present difficulties for participation in the study.
  • Stage IV cancer.
  • Any other clinical condition or previous therapy that contraindicates one or more of the techniques included in the programme, as the intervention may not be safe for the patient and therefore the person would not be eligible to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fundacion Hospital Ramón y Cajal

Madrid, 28834, Spain

Location

Related Publications (3)

  • Pellini F, Granuzzo E, Urbani S, Mirandola S, Caldana M, Lombardi D, Fiorio E, Mandara M, Pollini GP. Male Breast Cancer: Surgical and Genetic Features and a Multidisciplinary Management Strategy. Breast Care (Basel). 2020 Feb;15(1):14-20. doi: 10.1159/000501711. Epub 2019 Sep 13.

    PMID: 32231493BACKGROUND
  • Hidding JT, Beurskens CH, van der Wees PJ, van Laarhoven HW, Nijhuis-van der Sanden MW. Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review. PLoS One. 2014 May 9;9(5):e96748. doi: 10.1371/journal.pone.0096748. eCollection 2014.

    PMID: 24816774BACKGROUND
  • van Egmond MA, van der Schaaf M, Vredeveld T, Vollenbroek-Hutten MMR, van Berge Henegouwen MI, Klinkenbijl JHG, Engelbert RHH. Effectiveness of physiotherapy with telerehabilitation in surgical patients: a systematic review and meta-analysis. Physiotherapy. 2018 Sep;104(3):277-298. doi: 10.1016/j.physio.2018.04.004. Epub 2018 Jun 19.

    PMID: 30030037BACKGROUND

MeSH Terms

Conditions

Breast NeoplasmsMotor ActivityMuscle WeaknessLymphedemaFatigueDepression

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesBehaviorMuscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsLymphatic DiseasesHemic and Lymphatic DiseasesBehavioral Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The assessor will assess patients at baseline, 6 weeks, 12 weeks, and 6 months and will not know which arm of the study each patient belongs to.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Group 1. Conventional treatment. Patients will be treated by means of a physiotherapy programme without digital support. They will be given a written document with exercises and recommendations on the first day. Group 2. Experimental treatment. Patients will be treated with a digitally supported physiotherapy programme.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist

Study Record Dates

First Submitted

April 6, 2021

First Posted

April 8, 2021

Study Start

August 2, 2021

Primary Completion

October 28, 2024

Study Completion

December 30, 2024

Last Updated

February 26, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations